CZAR - ETF AI Analysis
Top Page
Themes Natural Monopoly ETF (CZAR)
Rating:71Outperform
Price Target:―
Positive Factors
Resilient Top Holdings Mix
Several of the largest positions, such as BAE Systems, Honeywell, BlackRock, ASX, and Raymond James, have shown strong or steady performance, helping to offset weaker names in the portfolio.
Broad Sector Diversification
The ETF spreads its investments across many sectors, with meaningful exposure to technology, industrials, financials, health care, and consumer companies, which helps reduce reliance on any single industry.
Global Footprint with U.S. Core
While the fund is anchored in U.S. stocks, it also holds companies from the UK, Australia, Europe, and Asia, providing some international diversification.
Negative Factors
Recent Weak Performance
The ETF has delivered negative returns over the past month, three months, and year to date, which may concern investors looking for near-term momentum.
Mixed Results Among Top Holdings
Several major positions such as Broadcom, Fortive, Cisco, and Mastercard have shown weak performance this year, which has weighed on the fund’s overall results.
Small Asset Base
The fund manages a relatively low level of assets, which can sometimes mean lower trading volume and wider bid–ask spreads for investors.
CZAR vs. SPDR S&P 500 ETF (SPY)
AUM1.53M
RegionDeveloped Markets
Expense Ratio0.35%
Beta0.71
IssuerThemes
Inception DateDec 13, 2023
Dividend Yield2.39%
Asset ClassEquity
Index TrackedSolactive Natural Monopoly Index - Benchmark TR Gross
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume235
30 Day Avg. Volume269
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
37.23Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering97
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CZAR Summary
CZAR, the Themes Natural Monopoly ETF, tracks the Solactive Natural Monopoly Index, focusing on companies that dominate their markets and are hard to compete with. It holds well-known names like Broadcom and Mastercard, along with leaders in technology, finance, and industrials from the U.S. and other developed countries. Someone might invest in CZAR to tap into the long-term growth and stability of market leaders while getting global diversification in a single fund. A key risk is that these stocks can still go up and down with the overall market and with changes in regulation.
How much will it cost me?The Themes Natural Monopoly ETF (CZAR) has an expense ratio of 0.35%, meaning you’ll pay $3.50 per year for every $1,000 invested. This cost is slightly higher than average for ETFs because it is actively managed, focusing on a unique niche of companies with natural monopolies. Active management typically involves more research and oversight, which can increase costs.
What would affect this ETF?The CZAR ETF, with its focus on dominant companies in developed markets, could benefit from continued technological innovation and strong consumer demand in sectors like Technology and Industrials, which make up a significant portion of its portfolio. However, rising interest rates or stricter regulations in industries such as Financials or Technology could negatively impact growth prospects for some of its top holdings like Mastercard, Broadcom, or Meta Platforms. Global economic conditions and geopolitical tensions may also influence the performance of its diverse sector exposure.
CZAR Top 10 Holdings
CZAR is leaning heavily on industrial and financial “tollbooths” to drive returns, with Honeywell, Fortive, and BAE Systems doing much of the heavy lifting as their shares keep rising on solid fundamentals. Cisco is also pulling its weight, adding a steady tech backbone to the portfolio. On the flip side, payment giants Visa and Mastercard are losing steam, acting as mild brakes on performance, while Broadcom’s mixed trading pattern adds some wobble. Overall, the fund is concentrated in developed-market industrials, financials, and select tech leaders.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| BAE Systems | 5.46% | $83.62K | £67.95B | 43.85% | 61 Neutral | |
| Honeywell International | 4.93% | $75.51K | $147.11B | 10.34% | 77 Outperform | |
| Cisco Systems | 4.17% | $63.92K | $313.11B | 31.46% | 77 Outperform | |
| Fortive | 4.03% | $61.76K | $17.19B | -28.07% | 72 Outperform | |
| Broadcom | 3.83% | $58.63K | $1.52T | 70.30% | 76 Outperform | |
| ASX | 3.75% | $57.47K | AU$9.68B | -12.36% | 54 Neutral | |
| Raymond James Financial | 3.37% | $51.67K | $28.48B | -0.45% | 76 Outperform | |
| Mastercard | 3.32% | $50.79K | $451.77B | -4.09% | 75 Outperform | |
| Visa | 3.27% | $50.06K | $587.93B | -7.37% | 70 Outperform | |
| BlackRock | 3.26% | $49.90K | $158.43B | 1.29% | 77 Outperform |
CZAR Technical Analysis
Negative
―
Price Trends
31.89
Negative
31.78
Negative
31.60
Negative
Market Momentum
-0.27
Positive
40.94
Neutral
18.32
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For CZAR, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 31.53, equal to the 50-day MA of 31.89, and equal to the 200-day MA of 31.60, indicating a bearish trend. The MACD of -0.27 indicates Positive momentum. The RSI at 40.94 is Neutral, neither overbought nor oversold. The STOCH value of 18.32 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CZAR.
CZAR Peer Comparison
Comparison Results
Performance Comparison
CZAR
Themes Natural Monopoly ETF
31.01
1.55
5.26%
WLDR
Affinity World Leaders Equity ETF
―
―
―
KNO
AXS Knowledge Leaders ETF
―
―
―
RW
Rainwater Equity ETF
―
―
―
HDMV
First Trust Horizon Managed Volatility Developed Intl ETF
―
―
―
GLBL
Pacer MSCI World Industry Advantage ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents